Showing 1 - 7 results of 7 for search 'A. Stolk', query time: 0.03s Refine Results
  1. 1
    Predicting the risk and speed of drug resistance emerging in soil-transmitted helminths during preventive chemotherapy

    Predicting the risk and speed of drug resistance emerging in soil-transmitted helminths during preventive chemotherapy by Luc E. Coffeng, Wilma A. Stolk, Sake J. de Vlas

    Published 2024-02-01
    Get full text
    Article
  2. 2
    Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis.

    Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis. by Wilma A Stolk, Quirine A ten Bosch, Sake J de Vlas, Peter U Fischer, Gary J Weil, Ann S Goldman

    Published 2013-01-01
    Get full text
    Article
  3. 3
    How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?

    How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment? by Natalie V S Vinkeles Melchers, Wilma A Stolk, Michele E Murdoch, Belén Pedrique, Marielle Kloek, Roel Bakker, Sake J de Vlas, Luc E Coffeng

    Published 2021-06-01
    Get full text
    Article
  4. 4
    Impact of ivermectin and vector control on onchocerciasis transmission in Togo: Assessing the empirical evidence on trends in infection and entomological indicators.

    Impact of ivermectin and vector control on onchocerciasis transmission in Togo: Assessing the empirical evidence on trends in infection and entomological indicators. by Natalie V S Vinkeles Melchers, Sibabi Agoro, Kwamy Togbey, Koffi Padjoudoum, Ibrahim Gado Telou, Potchoziou Karabou, Touka Djatho, Michel Datagni, Ameyo Monique Dorkenoo, Yao Kassankogno, Rachel Bronzan, Wilma A Stolk

    Published 2024-07-01
    Get full text
    Article
  5. 5
    Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8<sup>+</sup> T Cell Responses via CD169<sup>+</sup> Macrophages and cDC1

    Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8<sup>+</sup> T Cell Responses via CD169<sup>+</sup> Macrophages and cDC1 by Joanna Grabowska, Dorian A. Stolk, Maarten K. Nijen Twilhaar, Martino Ambrosini, Gert Storm, Hans J. van der Vliet, Tanja D. de Gruijl, Yvette van Kooyk, Joke M.M. den Haan

    Published 2021-01-01
    Get full text
    Article
  6. 6
    Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells

    Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells by Aram M. de Haas, Dorian A. Stolk, Sjoerd T. T. Schetters, Laura Goossens-Kruijssen, Eelco Keuning, Martino Ambrosini, Louis Boon, Hakan Kalay, Gert Storm, Hans J. van der Vliet, Tanja D. de Gruijl, Yvette van Kooyk

    Published 2024-04-01
    Get full text
    Article
  7. 7
    Impact assessment of onchocerciasis through lymphatic filariasis transmission assessment surveys using Ov-16 rapid diagnostic tests in Sierra Leone

    Impact assessment of onchocerciasis through lymphatic filariasis transmission assessment surveys using Ov-16 rapid diagnostic tests in Sierra Leone by Ibrahim Kargbo-Labour, Mohamed S. Bah, Natalie V. S. Vinkeles Melchers, Abdulai Conteh, Victoria Redwood-Sawyerr, Wilma A. Stolk, Jusufu Paye, Mustapha Sonnie, Amy Veinoglou, Joseph B. Koroma, Mary H. Hodges, Angela M. Weaver, Yaobi Zhang

    Published 2024-03-01
    Get full text
    Article

Search Tools: